The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global NGS Sequencers Market Research Report 2024

Global NGS Sequencers Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1765164

No of Pages : 100

Ask Your Query

Synopsis
NGS sequencer is a massively parallel sequencing technology that can perform sequencing with ultra-high throughput, ultra-strong scalability, and ultra-fast speed. This technique is used to determine the order of nucleotides throughout the genome or in targeted regions of DNA or RNA.

Global NGS Sequencers market is projected to reach US$ 2477.8 million in 2029, increasing from US$ 877 million in 2022, with the CAGR of 16.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole NGS Sequencers market research.

Key manufacturers engaged in the NGS Sequencers industry include Illumina Inc., BioMérieux, Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, BGI, PacBio, Agilent Technologies and Gene, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of NGS Sequencers were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole NGS Sequencers market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global NGS Sequencers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Illumina Inc.
  • BioMérieux
  • Life Technologies Corporation
  • Thermo Fisher Scientific
  • Memorial Sloan Kettering
  • BGI
  • PacBio
  • Agilent Technologies
  • Gene
  • Roche
  • Beckman Coulter
  • PerkinElmer
  • GTH.O
  • Boao Bio Group
  • Oxford Nanopore Technologies

Segment by Type

  • Reversible End Termination Sequencing
  • Semiconductor Sequencing
  • Combined Probe Anchored Polymerization Sequencing

Segment by Application

  • Hospitals and Clinics
  • Academic and Research Institutions
  • Pharmaceutical and Biotech Companies
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The NGS Sequencers report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 NGS Sequencers Market Overview
1.1 Product Overview and Scope of NGS Sequencers
1.2 NGS Sequencers Segment by Type
1.2.1 Global NGS Sequencers Market Value Comparison by Type (2023-2029)
1.2.2 Reversible End Termination Sequencing
1.2.3 Semiconductor Sequencing
1.2.4 Combined Probe Anchored Polymerization Sequencing
1.3 NGS Sequencers Segment by Application
1.3.1 Global NGS Sequencers Market Value by Application: (2023-2029)
1.3.2 Hospitals and Clinics
1.3.3 Academic and Research Institutions
1.3.4 Pharmaceutical and Biotech Companies
1.3.5 Other
1.4 Global NGS Sequencers Market Size Estimates and Forecasts
1.4.1 Global NGS Sequencers Revenue 2018-2029
1.4.2 Global NGS Sequencers Sales 2018-2029
1.4.3 Global NGS Sequencers Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 NGS Sequencers Market Competition by Manufacturers
2.1 Global NGS Sequencers Sales Market Share by Manufacturers (2018-2023)
2.2 Global NGS Sequencers Revenue Market Share by Manufacturers (2018-2023)
2.3 Global NGS Sequencers Average Price by Manufacturers (2018-2023)
2.4 Global NGS Sequencers Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of NGS Sequencers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of NGS Sequencers, Product Type & Application
2.7 NGS Sequencers Market Competitive Situation and Trends
2.7.1 NGS Sequencers Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest NGS Sequencers Players Market Share by Revenue
2.7.3 Global NGS Sequencers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 NGS Sequencers Retrospective Market Scenario by Region
3.1 Global NGS Sequencers Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global NGS Sequencers Global NGS Sequencers Sales by Region: 2018-2029
3.2.1 Global NGS Sequencers Sales by Region: 2018-2023
3.2.2 Global NGS Sequencers Sales by Region: 2024-2029
3.3 Global NGS Sequencers Global NGS Sequencers Revenue by Region: 2018-2029
3.3.1 Global NGS Sequencers Revenue by Region: 2018-2023
3.3.2 Global NGS Sequencers Revenue by Region: 2024-2029
3.4 North America NGS Sequencers Market Facts & Figures by Country
3.4.1 North America NGS Sequencers Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America NGS Sequencers Sales by Country (2018-2029)
3.4.3 North America NGS Sequencers Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe NGS Sequencers Market Facts & Figures by Country
3.5.1 Europe NGS Sequencers Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe NGS Sequencers Sales by Country (2018-2029)
3.5.3 Europe NGS Sequencers Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific NGS Sequencers Market Facts & Figures by Country
3.6.1 Asia Pacific NGS Sequencers Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific NGS Sequencers Sales by Country (2018-2029)
3.6.3 Asia Pacific NGS Sequencers Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America NGS Sequencers Market Facts & Figures by Country
3.7.1 Latin America NGS Sequencers Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America NGS Sequencers Sales by Country (2018-2029)
3.7.3 Latin America NGS Sequencers Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa NGS Sequencers Market Facts & Figures by Country
3.8.1 Middle East and Africa NGS Sequencers Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa NGS Sequencers Sales by Country (2018-2029)
3.8.3 Middle East and Africa NGS Sequencers Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global NGS Sequencers Sales by Type (2018-2029)
4.1.1 Global NGS Sequencers Sales by Type (2018-2023)
4.1.2 Global NGS Sequencers Sales by Type (2024-2029)
4.1.3 Global NGS Sequencers Sales Market Share by Type (2018-2029)
4.2 Global NGS Sequencers Revenue by Type (2018-2029)
4.2.1 Global NGS Sequencers Revenue by Type (2018-2023)
4.2.2 Global NGS Sequencers Revenue by Type (2024-2029)
4.2.3 Global NGS Sequencers Revenue Market Share by Type (2018-2029)
4.3 Global NGS Sequencers Price by Type (2018-2029)
5 Segment by Application
5.1 Global NGS Sequencers Sales by Application (2018-2029)
5.1.1 Global NGS Sequencers Sales by Application (2018-2023)
5.1.2 Global NGS Sequencers Sales by Application (2024-2029)
5.1.3 Global NGS Sequencers Sales Market Share by Application (2018-2029)
5.2 Global NGS Sequencers Revenue by Application (2018-2029)
5.2.1 Global NGS Sequencers Revenue by Application (2018-2023)
5.2.2 Global NGS Sequencers Revenue by Application (2024-2029)
5.2.3 Global NGS Sequencers Revenue Market Share by Application (2018-2029)
5.3 Global NGS Sequencers Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Illumina Inc.
6.1.1 Illumina Inc. Corporation Information
6.1.2 Illumina Inc. Description and Business Overview
6.1.3 Illumina Inc. NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Illumina Inc. NGS Sequencers Product Portfolio
6.1.5 Illumina Inc. Recent Developments/Updates
6.2 BioMérieux
6.2.1 BioMérieux Corporation Information
6.2.2 BioMérieux Description and Business Overview
6.2.3 BioMérieux NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BioMérieux NGS Sequencers Product Portfolio
6.2.5 BioMérieux Recent Developments/Updates
6.3 Life Technologies Corporation
6.3.1 Life Technologies Corporation Corporation Information
6.3.2 Life Technologies Corporation Description and Business Overview
6.3.3 Life Technologies Corporation NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Life Technologies Corporation NGS Sequencers Product Portfolio
6.3.5 Life Technologies Corporation Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Thermo Fisher Scientific NGS Sequencers Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Memorial Sloan Kettering
6.5.1 Memorial Sloan Kettering Corporation Information
6.5.2 Memorial Sloan Kettering Description and Business Overview
6.5.3 Memorial Sloan Kettering NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Memorial Sloan Kettering NGS Sequencers Product Portfolio
6.5.5 Memorial Sloan Kettering Recent Developments/Updates
6.6 BGI
6.6.1 BGI Corporation Information
6.6.2 BGI Description and Business Overview
6.6.3 BGI NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.6.4 BGI NGS Sequencers Product Portfolio
6.6.5 BGI Recent Developments/Updates
6.7 PacBio
6.6.1 PacBio Corporation Information
6.6.2 PacBio Description and Business Overview
6.6.3 PacBio NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 PacBio NGS Sequencers Product Portfolio
6.7.5 PacBio Recent Developments/Updates
6.8 Agilent Technologies
6.8.1 Agilent Technologies Corporation Information
6.8.2 Agilent Technologies Description and Business Overview
6.8.3 Agilent Technologies NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Agilent Technologies NGS Sequencers Product Portfolio
6.8.5 Agilent Technologies Recent Developments/Updates
6.9 Gene
6.9.1 Gene Corporation Information
6.9.2 Gene Description and Business Overview
6.9.3 Gene NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Gene NGS Sequencers Product Portfolio
6.9.5 Gene Recent Developments/Updates
6.10 Roche
6.10.1 Roche Corporation Information
6.10.2 Roche Description and Business Overview
6.10.3 Roche NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Roche NGS Sequencers Product Portfolio
6.10.5 Roche Recent Developments/Updates
6.11 Beckman Coulter
6.11.1 Beckman Coulter Corporation Information
6.11.2 Beckman Coulter NGS Sequencers Description and Business Overview
6.11.3 Beckman Coulter NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Beckman Coulter NGS Sequencers Product Portfolio
6.11.5 Beckman Coulter Recent Developments/Updates
6.12 PerkinElmer
6.12.1 PerkinElmer Corporation Information
6.12.2 PerkinElmer NGS Sequencers Description and Business Overview
6.12.3 PerkinElmer NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.12.4 PerkinElmer NGS Sequencers Product Portfolio
6.12.5 PerkinElmer Recent Developments/Updates
6.13 GTH.O
6.13.1 GTH.O Corporation Information
6.13.2 GTH.O NGS Sequencers Description and Business Overview
6.13.3 GTH.O NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.13.4 GTH.O NGS Sequencers Product Portfolio
6.13.5 GTH.O Recent Developments/Updates
6.14 Boao Bio Group
6.14.1 Boao Bio Group Corporation Information
6.14.2 Boao Bio Group NGS Sequencers Description and Business Overview
6.14.3 Boao Bio Group NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Boao Bio Group NGS Sequencers Product Portfolio
6.14.5 Boao Bio Group Recent Developments/Updates
6.15 Oxford Nanopore Technologies
6.15.1 Oxford Nanopore Technologies Corporation Information
6.15.2 Oxford Nanopore Technologies NGS Sequencers Description and Business Overview
6.15.3 Oxford Nanopore Technologies NGS Sequencers Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Oxford Nanopore Technologies NGS Sequencers Product Portfolio
6.15.5 Oxford Nanopore Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 NGS Sequencers Industry Chain Analysis
7.2 NGS Sequencers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 NGS Sequencers Production Mode & Process
7.4 NGS Sequencers Sales and Marketing
7.4.1 NGS Sequencers Sales Channels
7.4.2 NGS Sequencers Distributors
7.5 NGS Sequencers Customers
8 NGS Sequencers Market Dynamics
8.1 NGS Sequencers Industry Trends
8.2 NGS Sequencers Market Drivers
8.3 NGS Sequencers Market Challenges
8.4 NGS Sequencers Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock